成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
Cato Research Chemicals Inc.
Firmenname:
Cato Research Chemicals Inc.
Telefon:
020-81960175
E-Mail:
3008394369@qq.com
Nationalit?t:
China
URL:
www.cato-chem.com/
Produkte insgesamt:
15726
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
Produktkatalog
Flomoxef Impurity 35
(2-Vinyl-1,3-dioxane-5,5-diyl)dimethanol
29178-30-1
C8H14O4
Decitabine Impurity 25
Flomoxef Impurity 34
Flomoxef Impurity 32
Flomoxef Impurity 33
Metronidazole Impurity 31
Tenofovir monopyrfuroxil enrutabine adduct
Terazidone Impurity 1
Tropinol enantiomer impurity
Valproate Impurity 47
Diethyldipropylmalonat
6065-63-0
C13H24O4
N-phenylpropionamide
Propionanilid
620-71-3
C9H11NO
Indacaterol Impurity 22
2598-30-3
C10H7NO2
Pazufloxacin Impurity 10
165071-09-0
C14H9FN2O4
Dronedarone Impurity 29
748763-03-3
C18H29NO3
Ethyl Trifluoromethanesulfonate
Ethyltrifluormethansulfonat
425-75-2
C3H5F3O3S
Ethacridine Lactate Impurity 31
36711-56-5
C14H12N2O3
Metoclopramide Impurity 43 HCl
22459-75-2
C14H20ClN3O4
Pazufloxacin Impurity 17
164851-44-9
C16H14FNO6
Pazufloxacin Impurity 11
165071-10-3
C14H10FNO6
Pazufloxacin Impurity 20
165071-03-4
C16H14FNO5
Tenofovir disoproxil Impurity 108
1962114-92-6
C29H44N10O14P2
Bisacodyl Impurity 9
53555-73-0
C19H17NO2
Pazufloxacin lmpurity21 HCI
171567-51-4
C15H16ClFN2O3
Hydroxychloroquine Impurity 47
Ketorolac Impurity 59
2705552-46-9
C19H22N2O5
Tenofovir dipivuroxime enrutabine adduct
1962114-98-2
C28H40FN8O13PS
Risperidone Impurity 25
832747-59-8
C11H14N2O
Ketorolac Impurity 56
952569-58-3
C8H9NO4
Ketorolac Impurity 55
Ketorolac Impurity 51
111122-84-0
C18H13NO2
Ketorolac Impurity 52
147088-89-9
C18H13NO2
(E)-4-(((2-fluorophenyl)imino)methyl)phenol
1829558-56-6
C13H10FNO
6-Hydroxy-4-Methylcoumarin
2373-31-1
C10H8O3
Ketorolac Impurity 57
130190-60-2
C11H8BrNO
Ketorolac Impurity 58
142231-05-8
C11H8BrNO
Oxiracetam impurity 22
25747-41-5
C4H7NO2
Phytyl Acetate (cis- and trans- mixture)
[R-[R*,R*-(E)]]-3,7,11,15-Tetramethylhexadec-2-enylacetat
10236-16-5
C22H42O2
4-Chloro-7-nitrobenzo-2-oxa-1,3-oxadiazole
4-Chlor-7-nitrobenzo-2-oxa-1,3-diazol
10199-89-0
C6H2ClN3O3
Ethyl 5-methylhexanoate
10236-10-9
C9H18O2
8-Benzyl 1,3-di-tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-1,3,8-tricarboxylate
1005187-65-4
C25H33N3O8
2-Naphthyl isocyanate
10124-78-4
C11H7N
Methyl 2-amino-3-bromo-5-chlorobenzoate
101080-36-8
C8H7BrClNO2
3-Hydroxyhexanoic Acid
10191-24-9
C6H12O3
Hex-3-en-1-yl 3-methylbutanoate
Hex-3-enylisovalerat
10032-11-8
C11H20O2
Istradefylline Impurity 20
1785764-26-2
C8H15ClN4O2
Amisulpride Impurity 11
261614-86-2
C7H15NO
Aripiprazole Impurity 61
63309-35-3
C13H16BrNO2
Istradefylline Impurity 15
89073-60-9
C8H12N4O3
Pyridine-2,5-dicarbonitrile
20730-07-8
C7H3N3
(2-(6-(Azepan-1-yl)pyridin-3-yl)pyrrolidin-1-yl)(phenyl)methanone
1352499-72-9
C22H27N3O
Triethyl Methanetricarboxylate
Triethylmethantricarboxylat
6279-86-3
C10H16O6
Revefenacin Dimer Impurity 8
Ozefloxacin Impurity 3
Vortioxetine Impurity 89
1019453-85-0
C14H15NS
Vortioxetine Impurity 51
1610527-49-5
C14H13NO2S
Cefaclor Impurity 20
Acrylic Acid Impurity 3
65967-52-4
C11H16O4
Isosorbide Impurity 21
28218-55-5
C6H12O5
P-hydroxyphenyl Glyoxal monohydrate
24645-80-5
C8H6O3
Pregabalin Impurity 15
1083246-65-4
C16H32N2O3
Pomalidomide Impurity 3
2635-64-5
C13H13N3O5
Carteolol Impurity 28
823-19-8
C6H10O2
Teneligliptin Impurity 16
Brivaracetam Impurity 84
2200297-71-6
C11H21BrO2
6-Methylnicotinonitrile
3222-48-8
C7H6N2
Diethyl 2-(4-chlorobenzamido)-2-((2-oxo-1,2-dihydroquinolin-4-yl)methyl)malonate
1028268-32-7
C24H23ClN2O6
(2S-trans)-Diltiazem Hydrochloride
103532-26-9
C22H27ClN2O4S
Catechol-d4
103963-58-2
C6H6O2
16a-Methyl Prednisolone
10417-63-7
C22H30O5
Cabotegravir
1051375-10-0
C19H17F2N3O5
Levomedetomidine N3-β-D-GlucuronideDISCONTINUED
1061620-92-5
C19H24N2O6
Leflunomide impurity 8
108605-62-5
C12H9F3N2O2
ilexsaponin B2
108906-69-0
C47H76O17
Ilexoside K
109008-26-6
C47H76O18
Ilexoside D
109008-27-7
C41H66O13
(3R,5R)-Rosuvastatin
1094100-06-7
C22H28FN3O6S
Ophiopogonin A
11054-24-3
C41H64O13
11130-20-4 silicic acid; tetrakis(tungsten oxide)
11130-20-4
H4O40SiW12
4-boron-
D
-phenylalanine
111821-49-9
C9H12BNO4
Ilexhainanoside D
1137648-52-2
C36H56O11
Pioglitazone-d4 (major)
1134163-31-7
C19H16D4N2O3S
Olopatadine Methyl Ester
113805-71-3
C21H23NO3
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylicacid 3-ethylester
113994-38-0
C19H21ClN2O5
1-Bromo-2,3,4,5-tetrachlorobenzene
1125-52-6
C6HBrCl4
Sorafenib beta-D-Glucuronide
1130164-93-0
C27H24ClF3N4O9
4-(tert-Butyl)benzenesulfonic acid
1133-17-1
C10H14O3S
Olopatadine Impurity 13
113835-76-0
C21H25NO2
Sitagliptin Impurity 124
1151240-88-8
C12H11F3O3
Chloroorienticin A
118395-73-6
C73H88Cl2N10O26
Ruxolitinib Impurity N5
1153949-38-2
C17H26BN3O2
2,6-Dichloroterephthalic acid
116802-97-2
C8H4Cl2O4
A0S961SVRW 1172-63-0 Jasmolin II Jasmolin II [BSI:ISO] Cyclopropanecarboxylic acid, 3-(3-methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethyl-, 2-methyl-4-oxo-3-(2-pentenyl)-2-cyclopenten-1-yl ester, (1R-(1alpha(S*(Z)),3beta(E)))- Cyclopropanecarboxylic acid, 3-((1E)-3-methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethyl-, (1S)-2-methyl-4-oxo-3-(2Z)-2-pentenyl-2-cyclopenten-1-yl ester, (1R,3R)- Jasmoline II [ISO-French] (1R-(1alpha(S*(Z)),3beta(E)))-2-Methyl-4-oxo-3-(2-pentenyl)-2-cyclopenten-1-yl 3-(3-methoxy-2-methyl-3-oxo-1-propenyl)-2,2-dimethylcyclopropanecarboxylate Jasmoline II UNII-A0S9
1172-63-0
C22H30O5
Methyl (Z)-1-acetyl-3-(ethoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
1175365-43-1
C21H19NO5
Licoricesaponin A3
118325-22-7
C48H72O21
Erythromycin 4'-
200802-92-2
C38H69NO13
4-(3-Chlorophenyl)piperidine-2,6-dione
113675-65-3
C11H10ClNO2
Vilanterol Impurity 54 HCI
1463889-71-5
C15H23Cl2NO2
(4AR,6R,7aS)-6-(6-amino-9H-purin-9-yl)-2-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide
1157-33-1
C10H12N5O5P
(±)-Hydroxybupropion-D6
1184984-06-2
C13H12ClD6NO2
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
Copyright 2019 ? ChemicalBook. All rights reserved